Standard of care in NSCLC requires testing for ALK, BRAF, EGFR, ERBB2, KRAS, MET, NTRK, RET, ROS1.

Download Study
Advanced lung cancer pre-treatment imaging.

Pre-treatment imaging

Advanced lung cancer post-treatment imaging.

Post-treatment imaging
*Representative patient images

Patient Case

Clinical presentation
  • 68-year-old male non-smoker initially presented with severe cough and nausea
  • Evaluation showed lung mass, and subsequent PET scan identified multiple metastatic lesions; patient was diagnosed with advanced NSC
  • While waiting for single-gene tissue testing results to be returned, guideline-recommended genomic testing with Guardant360® LDT liquid biopsy identified BRAF V600E in 7 days
  • The patient was put on BRAF/MET inhibitor combination and achieved a partial response

You might also be interested in

Advanced breast cancer imaging.
Advanced Breast Cancer

Standard of care testing for BRCA1/2, ERBB2 (HER2), MSI, ESR1, NTRK1/2/3, and PIK3CA.

Advanced CRC imaging.
Advanced CRC

Standard of care in CRC requires testing for BRAF, ERBB2 (HER2), KRAS, MSI, NRAS, and NTRK.